Efficacy of a multidisciplinary team for preventing hospital acquired invasive aspergillosis: A five years experience;Efficacité des mesures environnementales dans la prévention de l'aspergillose invasive nosocomiale liée aux travaux : bilan de cinq années d'expérience

Pathologie Biologie

Volumn 57, Issue 1, 2009, Pages 71-75

  Etancelin, P ^a   Silly, S ^a   Merle, V ^a   Bonmarchand, G ^a   Richard, J C ^a   Vannier, J P ^a   Nouvellon, M ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Construction works; Hospital acquired invasive aspergillosis; Prevention

Indexed keywords

ANTIFUNGAL AGENT;

ARTICLE; ASPERGILLOSIS; CONTROLLED STUDY; FOLLOW UP; HEMATOLOGY; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRESCRIPTION; PREVENTIVE HEALTH SERVICE; RISK FACTOR; THERAPY EFFECT;

AIR POLLUTION, INDOOR; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CHILD; CROSS INFECTION; DISINFECTION; DRUG PRESCRIPTIONS; DRUG UTILIZATION; ENVIRONMENT, CONTROLLED; ENVIRONMENTAL EXPOSURE; FILTRATION; FRANCE; HEMATOLOGY; HOSPITAL DEPARTMENTS; HOSPITAL DESIGN AND CONSTRUCTION; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; INTERDISCIPLINARY COMMUNICATION; MEDICAL ONCOLOGY; MEDICAL RECORDS; MIDDLE AGED; PEDIATRICS; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; SPORES, FUNGAL;

EID: 59649091434     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.07.004     Document Type: Article

References (21)

1. Upton A., Kirby K.A., Carpenter P., Boeckh M., and Marr K.A. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 44 (2007) 531-550
2. Denning D.W., Ribaud P., Milpied N., Caillot D., Herbrecht R., Thiel E., et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 35 (2002) 1273-1275
3. Herbrecht R., Denning D.W., Patterson T.F., Bennett J.E., Greene R.E., Oestmann J.W., et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347 6 (2002) 408-415
4. Crassard N., Hadden H., Piens M.A., Pondarré C., Hadden R., Galambrun C., et al. Invasive aspergillosis in a paediatric haematology department: a 15-year review. Mycoses 51 (2007) 109-116
5. Cornet M, Fleury L, Maslo C, Bernard JF, Brücker G and the Invasive Aspergillosis Surveillance Network of the Assistance Publique-Hôpitaux de Paris. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect 2002; 51:288-96.
6. Meersseman W., Vandecasteele S.J., Wilmer A., Verbeken E., Peetermans W.E., and Van Wijngaerden E. Invasive aspergillosis in critically III patients without malignancy. Am J Respir Crit Care Med 170 (2004) 621-625
7. Kontoyannis D.P., Boktour M., Hanna H., Torres H.A., Hachem R., and Raad I.I. Itraconazole added to lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer 103 (2005) 2334-2337
8. Hachem R.Y., Boktour M.R., Hanna H.A., Husni R.N., Torres H.A., Afif C., et al. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer 112 (2008) 1282-1287
9. Vonberg R.P., and Gastmeier P. Nosocomial aspergillosis in outbreak settings. J Hosp Infect 63 (2006) 246-254
10. CCLIN Sud-Ouest. Grille d'évaluation et mesures de prévention du risque infectieux suivant la nature des travaux. 2006.
11. Bocquet P, Aggoune M, Aussant M, Rykner G, Brücker G. Aspergillose invasive nosocomiale et travaux hospitaliers Recommandations. Guide de l'AP-HP Sept 1993.
12. Conférence de consensus. Prévention du risque aspergillaire chez les patients immunodéprimés. ANAES et SFHH. HygièneS 2000; 6:316-28.
13. Sehulster L., and Chinn R.Y.W. Guidelines for environmental infection control health-care facilities - recommendations of CDC and the healthcare infection control practices advisors committee (HICPAC). CDC Recommandations and Reports 52 (2003) 1-42
14. Pini G., Faggi E., Donato R., Sacco C., and Fanci R. Invasive pulmonary aspergillosis in neutropenic patients and the influence of hospital renovation. Mycoses 51 (2007) 117-122
15. Bénet T., Nicolle M.C., Thiebaut A., Piens M.A., Nicolini F.E., Thomas X., et al. Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. Clin Infect Dis 45 (2007) 682-686
16. Castel O., Samson P., and Bousseau A. Gestion des travaux à l'hôpital: la contribution du CLIN et de l'équipe opérationnelle d'hygiène hospitalière. HygièneS 4 (2007) 26476
17. Berthelot P., Loulergue P., Raberin H., Turco M., Mounier C., Tran Manh Sung R., et al. Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards. Clin Microbiol Infect 12 (2006) 738-744
18. Chang C.C., Cheng A.C., Devitt B., Hughes A.J., Campbell P., Styles K., et al. Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works. J Hosp Infect 69 (2008) 33-38
19. Fourneret-Vivier A., Lebeau B., Mallaret M.R., Brenier-Pinchard M.P., Brion J.P., Pinel C., et al. Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000-2002). J. Hosp Infect 62 (2006) 22-28
20. Pottecher B. Risque environnemental d'aspergillose. HygièneS 6 (2000) 336-341
21. Poirot J.L., Fort M.H., Isnard F., Nesa D., Lortholary J., Floirot S., et al. Conduite à tenir en cas de travaux: notre expérience à l'hôpital St-Antoine. HygièneS 6 (2000) 431-439